article thumbnail

Increasing Primary Care Research Workforce and Output through T32 Primary Care Fellowship Training [Education and training]

Annals of Family Medicine

Culturally-competent, high-quality training is provided via coursework, seminars/workshops, and mentored, hands-on research. Our T32 program, with our CTSA’s support, will be well-positioned to compete for funding renewal in 2026. SETTING: Academic medical center. CONCLUSION: Research training is accessible to PC departments.

article thumbnail

Health professionals speak out against the new nuclear arms race

Common Sense Family Doctor

The last of the nuclear arms accords, the New START treaty between the United States and the Russian Federation, is set to expire in 2026. Both countries are spending enormous amounts to modernize their existing arsenals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

News & Notes: Spring 2025

ABIM

Blueprints provide an outline of what content will appear on an assessment and the relative percentage of the assessment covered by each topic area. The rigorous, formalized blueprint review process includes several steps to gather feedback from physicians, medical specialty societies and medical educators.

article thumbnail

HP&M Director, Allyson Mullen, Appointed to the Association of Medical Diagnostic Manufacturers 2024-2026 Board of Directors

FDA Law Blog

Mullen brings to the AMDM board a wealth of knowledge and expertise gained from her years of providing counsel to medical device and IVD manufacturers. AMDM facilitates educational resources within the in vitro diagnostic industry. Mullen’s extensive experience and contributions to the field of in vitro diagnostic (IVD) regulation.

article thumbnail

FDA Hosts Webinar for Stage 1 Requirements under LDT Final Rule

FDA Law Blog

Instead, we focus here on the few notable statements that provide new or more detailed guidance than FDA has previously offered. Prior to February 2, 2026, FDA also said that it does not intend to enforce complaint requirements under 21 CFR 820.198 for developers that are already in compliance with the complaint requirements under ISO 13485.

article thumbnail

A Temporary Extension for the Rare Pediatric Disease Priority Review Voucher with a Longer-Term Extension in Sight?

FDA Law Blog

No rare pediatric disease vouchers could be awarded even to designated applications after September 30, 2026. While the dates have been written in the law, the previous extensions provided a reasonable hope that the program would continue. We heard and felt the anxiety from many of our clients about the uncertainty this caused.

article thumbnail

Hematology Board Meeting Summary | Spring 2025

ABIM

The group discussed policy shifts and potential implications for graduate medical education and health equity. Dr. McDonald acknowledged that recent executive orders have emphasized more competition in medical and legal education accreditation, but reaffirmed ABIM’s commitment to evidence-based practice and health equity.